Advanced
search

Search results

1 – 10 of 13
View access options
Expert briefing
Publication date: 1 March 2024
Expert Briefings Powered by Oxford Analytica

The vote was lost following Germany’s decision to oppose the directive, which encouraged others to abstain. There are only a few weeks left for the Council to vote again on the…

View access options
Expert briefing
Publication date: 24 April 2023
Expert Briefings Powered by Oxford Analytica

This turnout was a far milder contraction than the many assessments made at the outset of the invasion of Ukraine of its likely impact on the Russian economy. It prompted a public…

View access options
Expert briefing
Publication date: 10 January 2023
Expert Briefings Powered by Oxford Analytica

Orban's government is hiking taxes on several sectors to plug a widening fiscal deficit, amid concern that the country will not receive substantial EU funding. Unpredictable…

View access options
Expert briefing
Publication date: 7 December 2017
Expert Briefings Powered by Oxford Analytica

The controversy over declining competitiveness.
View access options
Expert briefing
Publication date: 12 July 2019
Expert Briefings Powered by Oxford Analytica

Trudeau will spend the summer campaigning for re-election, defending his administration’s record while underscoring unfinished business for a second term.
View access options
Expert briefing
Publication date: 24 June 2015
Expert Briefings Powered by Oxford Analytica

The impact of the diverted profits tax.
View access options
Expert briefing
Publication date: 9 June 2021
Expert Briefings Powered by Oxford Analytica

The government’s plan signals not only a new era in Hungarian-Chinese relations but also China’s more intensive presence within the EU. Heated debates within Hungary and the EU…

View access options
Expert briefing
Publication date: 8 September 2017
Expert Briefings Powered by Oxford Analytica

The US cannabis market.
View access options
Expert briefing
Publication date: 18 March 2019
Expert Briefings Powered by Oxford Analytica

Ireland's foreign policy.
View access options
Expert briefing
Publication date: 25 September 2020
Expert Briefings Powered by Oxford Analytica

Amid one of the steepest economic contractions in Europe, with GDP expected to shrink by 11% this year, the relaunch programme aims to reduce the tax burden on business and to…

Access

Year

Content type

Refine By Country
{"A":[{"count":"1","title":"Australia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Australia%22"}],"B":[{"count":"1","title":"Belgium","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Belgium%22"},{"count":"1","title":"Bulgaria","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Bulgaria%22"}],"C":[{"count":"3","title":"Canada","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Canada%22"},{"count":"1","title":"Chile","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Chile%22"},{"count":"4","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22China%22"},{"count":"1","title":"Colombia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Colombia%22"}],"F":[{"count":"3","title":"France","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22France%22"}],"G":[{"count":"2","title":"Germany","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Germany%22"},{"count":"1","title":"Greece","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Greece%22"}],"H":[{"count":"2","title":"Hungary","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Hungary%22"}],"I":[{"count":"1","title":"Indonesia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Indonesia%22"},{"count":"4","title":"Ireland","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Ireland%22"}],"J":[{"count":"1","title":"Japan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Japan%22"},{"count":"1","title":"Jordan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Jordan%22"}],"L":[{"count":"1","title":"Liberia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Liberia%22"},{"count":"1","title":"Luxembourg","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Luxembourg%22"}],"M":[{"count":"2","title":"Mexico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Mexico%22"}],"N":[{"count":"1","title":"New Zealand","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22New+Zealand%22"}],"R":[{"count":"1","title":"Russia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Russia%22"}],"S":[{"count":"1","title":"Singapore","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Singapore%22"}],"U":[{"count":"1","title":"Ukraine","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22Ukraine%22"},{"count":"3","title":"United Kingdom","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22United+Kingdom%22"},{"count":"1","title":"United Nations","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22United+Nations%22"},{"count":"6","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22fiscal%22+AND+keyword-topical%3A%22corporate%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-country%3A%22United+States%22"}]}
1 – 10 of 13
Manage cookies

We’re listening — tell us what you think

Join us on our journey